artesunic acid has been researched along with Glioblastoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Che, F; Peng, S; Song, Q; Zhu, X | 1 |
| Chai, T; Du, Q; Hanif, S; Ismail, M; Li, Y; Muhammad, P; Shi, B; Yang, W; Zhang, D; Zheng, M | 1 |
| Beltzig, L; Christmann, M; Kaina, B | 1 |
| Ding, W; Liao, L; Liao, Y; Liu, J; Tang, Q; Zhao, J | 1 |
| Efferth, T; Giordano, FA; Krishna, S; Schmiedek, P; Schöttler, U; Wenz, F | 2 |
| Cui, HJ; Weng, X; Zhu, SQ | 1 |
| Debatin, KM; Dwucet, A; Halatsch, ME; Karpel-Massler, G; Kast, RE; Nonnenmacher, L; Westhoff, MA; Wirtz, CR | 1 |
| Halatsch, ME; Karpel-Massler, G; Kast, RE | 1 |
| Lee, TY; Lu, H; Sheng, R; Zhang, C | 1 |
| Efferth, T; Hehlgans, S; Reichert, S; Reinboldt, V; Rödel, C; Rödel, F | 1 |
| Efferth, T; Gebhart, E; Halatsch, ME; Ramirez, T | 1 |
1 review(s) available for artesunic acid and Glioblastoma
| Article | Year |
|---|---|
Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; Chemical and Drug Induced Liver Injury; Chemoradiotherapy; Dacarbazine; Drugs, Chinese Herbal; Female; Glioblastoma; Humans; Temozolomide | 2017 |
11 other study(ies) available for artesunic acid and Glioblastoma
| Article | Year |
|---|---|
Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells.
Topics: Antimalarials; Antineoplastic Agents; Artesunate; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Ferroptosis; Glioblastoma; Homeostasis; Humans; Iron; MAP Kinase Signaling System; Molecular Targeted Therapy; Reactive Oxygen Species | 2022 |
Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Apolipoproteins E; Artesunate; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Liposomes; Mice; Temozolomide; Xenograft Model Antitumor Assays | 2022 |
Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics.
Topics: Artesunate; Cellular Senescence; Curcumin; Glioblastoma; Humans; Lomustine; Neoplasm Recurrence, Local; NF-kappa B; Poly(ADP-ribose) Polymerase Inhibitors; Senotherapeutics; Temozolomide | 2022 |
Lower dose of metformin combined with artesunate induced autophagy-dependent apoptosis of glioblastoma by activating ROS-AMPK-mTOR axis.
Topics: AMP-Activated Protein Kinases; Apoptosis; Artesunate; Autophagy; Glioblastoma; Humans; Metformin; Reactive Oxygen Species; TOR Serine-Threonine Kinases | 2023 |
Answer to the comment of Hai Lu et al. regarding "Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report and review of the literature. Arch Toxicol (2016)".
Topics: Artemisinins; Artesunate; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Dacarbazine; Glioblastoma; Humans; Temozolomide | 2017 |
[Artesunate inhibits proliferation of glioblastoma cells by arresting cell cycle].
Topics: Antineoplastic Agents; Apoptosis; Artesunate; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Glioblastoma; Humans | 2018 |
Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Dacarbazine; Drug Synergism; Glioblastoma; Humans; Inhibitory Concentration 50; Necrosis; Temozolomide | 2014 |
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Artemisinins; Artesunate; Auranofin; Brain Neoplasms; Captopril; Celecoxib; Dacarbazine; Disulfiram; Glioblastoma; Humans; Itraconazole; Molecular Targeted Therapy; Morpholines; Neoplasm Recurrence, Local; Pyrazoles; Ritonavir; Sertraline; Signal Transduction; Sulfonamides; Temozolomide; Treatment Outcome | 2014 |
Comments regarding "Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature".
Topics: Artemisinins; Artesunate; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Dacarbazine; Glioblastoma; Humans; Temozolomide | 2017 |
A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin.
Topics: Apoptosis; Artemisinins; Artesunate; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Repair; Dose-Response Relationship, Drug; Down-Regulation; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Neoplasm Proteins; Radiation-Sensitizing Agents; Survivin | 2012 |
Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; Cell Division; Cell Line; Cluster Analysis; Drug Screening Assays, Antitumor; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Glioblastoma; Humans; Nucleic Acid Hybridization; Quinazolines; Sesquiterpenes; Tumor Cells, Cultured | 2004 |